Literature DB >> 28530712

The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection.

Howell F Moffett1, Adam N R Cartwright1, Hye-Jung Kim1, Jernej Godec2, Jason Pyrdol1, Tarmo Äijö3, Gustavo J Martinez4, Anjana Rao4, Jun Lu5, Todd R Golub5, Harvey Cantor1, Arlene H Sharpe2, Carl D Novina1, Kai W Wucherpfennig1,2.   

Abstract

During infection, antigen-specific T cells undergo tightly regulated developmental transitions controlled by transcriptional and post-transcriptional regulation of gene expression. We found that the microRNA miR-31 was strongly induced by activation of the T cell antigen receptor (TCR) in a pathway involving calcium and activation of the transcription factor NFAT. During chronic infection with lymphocytic choriomeningitis virus (LCMV) clone 13, miR-31-deficent mice recovered from clinical disease, while wild-type mice continued to show signs of disease. This disease phenotype was explained by the presence of larger numbers of cytokine-secreting LCMV-specific CD8+ T cells in miR-31-deficent mice than in wild-type mice. Mechanistically, miR-31 increased the sensitivity of T cells to type I interferons, which interfered with effector T cell function and increased the expression of several proteins related to T cell dysfunction during chronic infection. These studies identify miR-31 as an important regulator of T cell exhaustion in chronic infection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28530712      PMCID: PMC5753758          DOI: 10.1038/ni.3755

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  63 in total

1.  An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.

Authors:  Andrew Stamm; Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  Virology       Date:  2012-02-04       Impact factor: 3.616

2.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.

Authors:  Chad J Creighton; Michael D Fountain; Zhifeng Yu; Ankur K Nagaraja; Huifeng Zhu; Mahjabeen Khan; Emuejevoke Olokpa; Azam Zariff; Preethi H Gunaratne; Martin M Matzuk; Matthew L Anderson
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

3.  Lymphocytic choriomeningitis virus (LCMV): propagation, quantitation, and storage.

Authors:  Raymond M Welsh; Mina O Seedhom
Journal:  Curr Protoc Microbiol       Date:  2008-02

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  Regulatory T-cell expansion during chronic viral infection is dependent on endogenous retroviral superantigens.

Authors:  George A Punkosdy; Melissa Blain; Deborah D Glass; Mary M Lozano; Leigh O'Mara; Jaquelin P Dudley; Rafi Ahmed; Ethan M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

6.  Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway.

Authors:  Taisuke Kajino; Hong Ren; Shun-Ichiro Iemura; Tohru Natsume; Bjarki Stefansson; David L Brautigan; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2006-11-01       Impact factor: 5.157

7.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

Review 8.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

9.  In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange.

Authors:  Melissa J Call; Xuechao Xing; Gregory D Cuny; Nilufer P Seth; Daniel M Altmann; Lars Fugger; Michelle Krogsgaard; Ross L Stein; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

10.  starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.

Authors:  Jian-Hua Yang; Jun-Hao Li; Peng Shao; Hui Zhou; Yue-Qin Chen; Liang-Hu Qu
Journal:  Nucleic Acids Res       Date:  2010-10-30       Impact factor: 16.971

View more
  30 in total

1.  MicroRNA regulation of CD8+ T cell responses.

Authors:  John D Gagnon; K Mark Ansel
Journal:  Noncoding RNA Investig       Date:  2019-08-26

2.  MicroRNA 31 inhibits CD8+ T-cell function by increasing its sensitivity to type I interferon signaling in chronic viral infection.

Authors:  Mingming Jia; Yiming Shao; Kunxue Hong
Journal:  Cell Mol Immunol       Date:  2017-10-02       Impact factor: 11.530

3.  miRNA-31 regulates the CD8 T cell response to type I IFNs during chronic infection.

Authors:  Marta Catalfamo
Journal:  Cell Mol Immunol       Date:  2017-09-04       Impact factor: 11.530

4.  Crucial role of miR-31 in induction of CD8+ T-cell exhaustion and reinforcement of type 1 interferon signaling.

Authors:  Lin Ying Li; Inkyu Hwang
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

5.  miR-31: a key player in CD8 T-cell exhaustion.

Authors:  Siddheshvar Bhela; Barry T Rouse
Journal:  Cell Mol Immunol       Date:  2017-09-11       Impact factor: 11.530

6.  MicroRNA in vivo precipitation identifies miR-151-3p as a computational unpredictable miRNA to target Stat3 and inhibits innate IL-6 production.

Authors:  Xiang Liu; Xiaoping Su; Sheng Xu; Huamin Wang; Dan Han; Jiangxue Li; Mingyan Huang; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2017-09-11       Impact factor: 11.530

Review 7.  Cell-intrinsic and -extrinsic roles of miRNAs in regulating T cell immunity.

Authors:  Sunglim Cho; Jiayi Dong; Li-Fan Lu
Journal:  Immunol Rev       Date:  2021-09-21       Impact factor: 12.988

8.  Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP.

Authors:  Benjamin C Houghton; Neelam Panchal; Simone A Haas; Kay O Chmielewski; Markus Hildenbeutel; Thomas Whittaker; Claudio Mussolino; Toni Cathomen; Adrian J Thrasher; Claire Booth
Journal:  Front Genome Ed       Date:  2022-05-23

Review 9.  Non-coding RNAs in CD8 T cell biology.

Authors:  Alexandria C Wells; Elena L Pobezinskaya; Leonid A Pobezinsky
Journal:  Mol Immunol       Date:  2020-02-18       Impact factor: 4.407

10.  Nicotine exhausts CD8+ T cells against tumor cells through increasing miR-629-5p to repress IL2RB-mediated granzyme B expression.

Authors:  Chun-Chia Cheng; Hsin-Chi Lin; Ya-Wen Chiang; Jungshan Chang; Zong-Lin Sie; Bi-Ling Yang; Ken-Hong Lim; Cheng-Liang Peng; Ai-Sheng Ho; Yi-Fang Chang
Journal:  Cancer Immunol Immunother       Date:  2020-11-03       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.